Rapid hair depigmentation in patient treated with pazopanib

Pazopanib is multitargeted tyrosine kinase inhibitor used for the treatment of metastatic renal cell carcinoma. Hair colour change is a common side effect of pazopanib therapy which usually develops gradually during few months of therapy. We report a case of the patient who developed multiple pazopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Šeparović, Robert, Pavlović, Mirjana, Silovski, Tajana, Tečić Vuger, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109726/
https://www.ncbi.nlm.nih.gov/pubmed/30139781
http://dx.doi.org/10.1136/bcr-2018-224209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109726/
https://www.ncbi.nlm.nih.gov/pubmed/30139781
http://dx.doi.org/10.1136/bcr-2018-224209

Ejemplares similares